Embera NeuroTherapeutics Overview
- Founded
- 2007

- Status
- Private
- Employees
- 5

- Latest Deal Type
- Series B
- Latest Deal Amount
- $6.13M

- Investors
- 14
Embera NeuroTherapeutics General Information
Description
Provider of medication intended to treat addiction by moderating activity in the stress response system. The company's medication reduces the cravings and loss of control that drive addiction by targeting multiple pathways, to maximize potential efficacy more than either drug used alone, enabling users to abstain from smoking and drug use.
Contact Information
Website
www.emberaneuro.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 29 Babe Ruth Drive
- Suite 210
- Sudbury, MA 01776
- United States
+1 (978) 000-0000
Embera NeuroTherapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
10. Later Stage VC (Series B) | 01-Aug-2020 | $6.13M | 000.00 | 000.00 | Completed | Clinical Trials - Phase 2 |
9. Grant | 26-Jul-2016 | 000.00 | 000.00 | Completed | Clinical Trials - Phase 1 | |
8. Later Stage VC (Series B) | 29-Jan-2016 | 00.00 | 000.00 | 0000 | Completed | Clinical Trials - Phase 1 |
7. Accelerator/Incubator | 05-Aug-2015 | 0000 | Completed | Generating Revenue | ||
6. Later Stage VC (Series A2) | 26-Feb-2015 | 00.000 | 0000 | 000.00 | Completed | Generating Revenue |
5. Grant | 01-Jul-2014 | 00.00 | 00.00 | Completed | Generating Revenue | |
4. Early Stage VC (Series A2) | 15-Aug-2011 | 00.00 | 00.00 | 00.000 | Completed | Startup |
3. Early Stage VC (Series A) | 03-Sep-2008 | 000 | 00.000 | Completed | Startup | |
2. Early Stage VC (Series A1) | 25-Aug-2008 | $1.36M | $1.96M | 0000 | Completed | Startup |
1. Early Stage VC (Series A) | 23-Jan-2007 | $600K | $600K | Completed | Startup |
Embera NeuroTherapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | 00,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.00 |
Series A2 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A1 | 1,357,100 | $0.001000 | $0.06 | $1 | $1 | 1x | $1 | 3.74% |
Embera NeuroTherapeutics Patents
Embera NeuroTherapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20200360400-A1 | Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease | Pending | 19-May-2017 | 0000000000 | |
AU-2018230521-A1 | Pharmaceutical compositions and uses thereof | Pending | 10-Mar-2017 | 0000000000 | |
US-11179377-B2 | Pharmaceutical compositions and uses thereof | Active | 10-Mar-2017 | 0000000000 | 000 |
US-20200054615-A1 | Pharmaceutical compositions and uses thereof | Granted | 10-Mar-2017 | 0000000000 | |
JP-2020511455-A | Pharmaceutical composition and use thereof | Pending | 10-Mar-2017 | A61K9/1611 | 0 |
Embera NeuroTherapeutics Executive Team (12)
Embera NeuroTherapeutics Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Dennis Purcell | Self | Board Member | 000 0000 |
Douglas Feltner | Embera NeuroTherapeutics | Founder & Development Advisory Board Member | 000 0000 |
Franz Hefti Ph.D | Self | Board Member | 000 0000 |
John Beaird | Self | Board Member | 000 0000 |
Joseph Lovett | Louisiana Funds | Board Member | 000 0000 |
Embera NeuroTherapeutics Signals
Growth Rate

0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile

-35.5%.
530%
Size Multiple

219x
Median
Size Multiple
219x, 100th %ile

0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialEmbera NeuroTherapeutics Investors (14)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Seven Funds | Venture Capital | Minority | 000 0000 | 000000 0 | |
ROSE RESEARCH CENTER, LLC | Corporation | 000 0000 | 000000 0 | ||
Keiretsu Forum | Venture Capital | Minority | 000 0000 | 000000 0 | |
NO/LA Angel Network | Angel Group | Minority | 000 0000 | 000000 0 | |
Technomark Life Sciences | Venture Capital | Minority | 000 0000 | 000000 0 |